Tempest Therapeutics, Inc. (TPST)
CIK 1544227 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Tempest Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Nov 3, 2026 | 3 | 0001213900-26-115343 |
| Nov 2, 2026 | 3 | 0001213900-26-114956 |
| Nov 2, 2026 | 4 | 0001213900-26-114957 |
| Nov 2, 2026 | ARS | 0001213900-26-114919 |
| Oct 30, 2026 | 8-K | 0001213900-26-114376 |
| Oct 26, 2026 | DEF 14A | 0001213900-26-112476 |
| Oct 20, 2026 | 8-K | 0001213900-26-111026 |
| Oct 20, 2026 | DEFA14A | 0001213900-26-111032 |
| Oct 19, 2026 | 8-K | 0001213900-26-110669 |
| Oct 16, 2026 | PRE 14A | 0001213900-26-110304 |
| Oct 14, 2026 | D | 0001213900-26-109190 |
| Oct 2, 2026 | 3 | 0001213900-26-106399 |
| Oct 2, 2026 | 424B3 | 0001213900-26-106362 |
| Oct 2, 2026 | 4 | 0001213900-26-106400 |
| Oct 1, 2026 | EFFECT | 9999999995-26-003135 |
| Sep 28, 2026 | 8-K | 0001213900-26-104034 |
| Sep 25, 2026 | S-3 | 0001213900-26-103526 |
| Sep 17, 2026 | 8-K | 0001193125-26-394492 |
| Sep 16, 2026 | DEFA14A | 0001193125-26-393155 |
| Sep 16, 2026 | 8-K | 0001193125-26-393151 |
| Sep 15, 2026 | 8-K | 0001193125-26-391903 |
| Sep 1, 2026 | 424B3 | 0001193125-26-378588 |
| Aug 31, 2026 | EFFECT | 9999999995-26-002838 |
| Aug 24, 2026 | 8-K | 0001193125-26-363695 |
| Aug 21, 2026 | S-1 | 0001193125-26-361240 |